Description
Since its creation in 2004, the European Clinical Research Infrastructure Network (ECRIN) has been striving to overcome the challenges to multinational trials in Europe.
A non-profit intergovernmental organisation, ECRIN offers diverse trial support services, which are mainly provided to investigator-initiated trials.
By supporting multi-country trials, ECRIN aims to facilitate access to patients, resources, and expertise, and, in turn, ensure more robust trial results for greater public health impact.
Organisation
ECRIN’s organisational model is based on country membership. It currently has seven Member Countries (France, Germany, Hungary, Italy, Norway, Portugal and Spain) and two Observer Countries (Czech Republic and Switzerland). Each country has a European Correspondent (EuCo) who manages the clinical trial portfolio and coordinates with the national scientific partner (i.e., network of clinical trial units, or CTUs), with support from the Paris-based Core Team.
In November 2013, ECRIN was awarded the status of European Research Infrastructure Consortium (ERIC) by the European Commission. This is a legal status recognised in all EU member states, designed to facilitate the establishment and operation of research infrastructures of European interest.
Types of Support
ECRIN provides support to sponsors in investigator-initiated trials for trial preparation (e.g., advice on funding applications and trial design, from site selection to logistics and insurance issues), the validation of study protocols (scientific and logistical review), and trial management (diverse services). It focuses on independent, multinational academic research as well as trials initiated by biotech and medical device small and medium enterprises (SMEs). To see the list of trials currently receiving ECRIN support, click here (www.ecrin.org/ecrin-activities/ecrin-supported-trials).
As part of its trial-support activities, ECRIN develops and maintains freely accessible tools such as databases on regulatory and ethical issues, outcome measures, and risk-based monitoring.
In addition, ECRIN contributes to collaborative projects aiming to establish shared services in biomedical areas, further develop infrastructure, and foster international cooperation in non-commercial trials.
A non-profit intergovernmental organisation, ECRIN offers diverse trial support services, which are mainly provided to investigator-initiated trials.
By supporting multi-country trials, ECRIN aims to facilitate access to patients, resources, and expertise, and, in turn, ensure more robust trial results for greater public health impact.
Organisation
ECRIN’s organisational model is based on country membership. It currently has seven Member Countries (France, Germany, Hungary, Italy, Norway, Portugal and Spain) and two Observer Countries (Czech Republic and Switzerland). Each country has a European Correspondent (EuCo) who manages the clinical trial portfolio and coordinates with the national scientific partner (i.e., network of clinical trial units, or CTUs), with support from the Paris-based Core Team.
In November 2013, ECRIN was awarded the status of European Research Infrastructure Consortium (ERIC) by the European Commission. This is a legal status recognised in all EU member states, designed to facilitate the establishment and operation of research infrastructures of European interest.
Types of Support
ECRIN provides support to sponsors in investigator-initiated trials for trial preparation (e.g., advice on funding applications and trial design, from site selection to logistics and insurance issues), the validation of study protocols (scientific and logistical review), and trial management (diverse services). It focuses on independent, multinational academic research as well as trials initiated by biotech and medical device small and medium enterprises (SMEs). To see the list of trials currently receiving ECRIN support, click here (www.ecrin.org/ecrin-activities/ecrin-supported-trials).
As part of its trial-support activities, ECRIN develops and maintains freely accessible tools such as databases on regulatory and ethical issues, outcome measures, and risk-based monitoring.
In addition, ECRIN contributes to collaborative projects aiming to establish shared services in biomedical areas, further develop infrastructure, and foster international cooperation in non-commercial trials.
Contact
Website: http://www.ecrin.org/
